Rabacfosadine
320 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
320
Total Reports
81
Deaths Reported
2530.0%
Death Rate
Active Ingredients
Rabacfosadine
Administration Routes
IntravenousUnknownParenteralOtherTopicalSubcutaneousIntramuscular
Species Affected
Dog 300
Unknown 17
Human 3
Most Affected Breeds
Dog (unknown) 60
Retriever - Golden 30
Unknown 22
Retriever - Labrador 20
Pit Bull 11
Shepherd Dog - German 10
Boxer (German Boxer) 9
Crossbred Canine/dog 8
Mountain Dog - Bernese 8
Pug 7
Most Reported Reactions
Diarrhoea 65
Lack of efficacy (neoplasia, no remission) 64
Death by euthanasia 63
Lack of efficacy - NOS 52
Anorexia 38
Decreased appetite 35
Lethargy (see also Central nervous system depression in 'Neurological') 30
Weight loss 25
Death 19
Vomiting 17
Neutropenia 16
Pulmonary fibrosis 14
Outcome Breakdown
Outcome Unknown
127 (41.5%)
Ongoing
68 (22.2%)
Euthanized
61 (19.9%)
Recovered/Normal
30 (9.8%)
Died
20 (6.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.